ScienceDex / Researcher record
Douglas K Graham
- Emory University (no department on record)
From the FY2024 NIH awards this investigator leads as contact PI. The department is the award's.
- Program Leader
- R01 Holder
- Translational
- Early Career
NIH Funding · FY2024
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $1,452,375 | 4 | #9,072 |
| 2025 | $861,265 | 2 | #18,920 |
| 2026 | $536,320 | 1 | #32,443 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY2024 · selected4 records
- FY20252 records
- FY20261 record
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Publications
Loading publications…
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 1945686Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award categories
- Pediatrics
- Pharmacology
FY2024 award records by amount
NIH award records listing Douglas K Graham as a PI. Multi-PI records show the full award amount for context.
- 1R01CA276135-01A1R01Co-investigatorDiscovery of a novel MDM2-tubulin signaling pathway as a therapeutic target in AMLEmory University · Pediatrics (NIH department code)$554.1Kaward amount
- 5R01CA249190-05R01Co-investigatorMERTK/AXL dual inhibitors provide novel treatment for cancer by targeting tumor cells and activating anti-tumor immunityUniversity of North Carolina at Chapel Hill · Pharmacology (NIH department code)$463.3Kaward amount
- 5R01CA259077-04R01Co-investigatorNovel TYRO3 inhibitors for treatment of cancerUniversity of North Carolina at Chapel Hill · Pharmacology (NIH department code)$306.9Kaward amount
- 3P50CA217691-05S1P50Contact PIAdministrative Supplement: Interim Funding for Emory Lung Cancer SPORE$128Kaward amount
Award organizations
Organizations that administered FY2024 awards listing Douglas K Graham as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardUniversity of North Carolina at Chapel Hill
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #9072
- 2025$2M Cumulative Funding
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2025R01 Grant Holder
- 2025Program/Center Grant Leader
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Douglas K Graham.